Streetbeat News

Earnings

EFSC

Enterprise Finl Servs (NASDAQ:EFSC) is set to release its quarterly earnings report on October 21, 2024. Analysts expect an EPS of $1.14. The company's past performance shows significant stock price movements following earnings announcements, with a notable 12.37% increase last quarter after an EPS beat. Investors are optimistic about potential positive guidance.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:22 pm

ARE

Alexandria Real Estate (NYSE:ARE) is set to release its quarterly earnings report on October 21, 2024. Analysts estimate an EPS of $2.37. The company's past performance shows mixed results, with a recent EPS beat leading to a share price drop. The stock is currently trading at $121.25, with a 52-week increase of 29.01%. Analysts have a Neutral consensus rating with a price target of $128.88, indicating a potential 6.29% upside.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:21 pm

GNTY

Guaranty Bancshares (NYSE:GNTY) is set to release its quarterly earnings report on October 21, 2024. Analysts expect an EPS of $0.60. The company's past performance shows a tendency for stock price changes following earnings announcements, with a notable 4.17% increase after the last quarter's EPS beat.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:21 pm

KREF

KKR Real Estate Finance (NYSE:KREF) is set to release its quarterly earnings on October 21, 2024. Analysts expect an EPS of $0.34. In the previous quarter, KREF beat EPS estimates, resulting in a significant share price increase. Investors are hopeful for positive results and guidance.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:21 pm

CATY

Cathay General (NASDAQ:CATY) is set to announce its quarterly earnings on October 21, 2024. Analysts expect an EPS of $0.95. The company's past performance shows mixed results, with a recent EPS beat leading to a slight stock price increase. Shares are up 38.83% over the past year.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:21 pm

SIGI

Selective Insurance Gr (NASDAQ:SIGI) is set to release its quarterly earnings on October 21, 2024. Analysts expect an EPS of $1.65. The company previously missed EPS by $2.58, leading to an 18.18% drop in share price. Investors are keen on the upcoming guidance, which can significantly impact stock prices.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:21 pm

NUE

Nucor (NYSE:NUE) is set to announce its quarterly earnings on October 21, 2024. Analysts estimate an EPS of $1.49. The market is optimistic about Nucor surpassing estimates and providing positive guidance. In the past, Nucor's EPS beats have not always led to positive stock price movements. Analysts rate Nucor as 'Outperform' with a price target of $170, suggesting a 7.53% upside. Nucor's financials show strong net margins and ROE but face challenges in revenue growth.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:20 pm

HXL

Hexcel (NYSE:HXL) is set to release its quarterly earnings on October 21, 2024, with analysts estimating an EPS of $0.47. Investors are keen on not just an earnings beat but also positive future guidance. Historically, Hexcel's stock price has shown varied reactions to earnings results. The company has a Neutral consensus rating with a potential 7.63% upside based on a $67 price target. Hexcel's financials show strong gross profit but challenges in return on equity.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:20 pm

WTFC

Wintrust Finl (NASDAQ:WTFC) is set to release its quarterly earnings on October 21, 2024. Analysts expect an EPS of $2.51. The company's past performance shows mixed results, with a notable EPS miss last quarter leading to a 4.98% drop in share price. Current trading price is $117.01, with a 56.54% increase over the past year.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:20 pm

MEDP

Medpace Hldgs (NASDAQ:MEDP) is set to release its quarterly earnings report on October 21, 2024, with analysts expecting an EPS of $2.80. Despite a previous EPS beat, the stock dropped 18.27% last quarter. Analysts have a Neutral consensus with a price target of $395.6, indicating a potential 15.37% upside. Medpace shows strong profitability and growth compared to peers.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 6:20 pm